Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05914987 · ClinicalTrials.gov registry record
Determining Individualized Cancer Therapy in Pancreatic Cancer
A clinical trial of Pancreatic Neoplasms, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05914987 is a study of Pancreatic Neoplasms that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 1,000 participants, above the 568-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (76% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05914987, a study of Pancreatic Neoplasms, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-therapeutic exploratory observational precision oncology study designed to collect and analyze data that demonstrate the clinical efficacy and tolerability of personalized treatments based on molecular tumor profiling assessments (i.e., matched therapy) in adult pancreatic cancer patients. Patient medical records, obtained both retrospectively and prospectively, will be examined for results of molecular profiling obtained through standard of care testing to help understand how well molecular testing might predicts response to therapy. Patient demographic and outcome parameters to be evaluated include, but are not limited to, tumor response, time to treatment failure, patient survival, and toxicity.
Conditions Studied
Interventions
- OTHER Targeted Therapy
Study Locations (1)
Wisconsin
- Froedtert Hospital and the Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2033-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05914987
The ClinicalTrials.gov registry entry for NCT05914987 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 568-participant average among 30 other Pancreatic Neoplasms trials with a reported enrollment target (76% higher). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Targeted Therapy is the first listed.
NCT05914987 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05914987 about?
NCT05914987 is a clinical study titled "Determining Individualized Cancer Therapy in Pancreatic Cancer". This is a non-therapeutic exploratory observational precision oncology study designed to collect and analyze data that demonstrate the clinical efficacy and tolerability of personalized treatments based on molecular tumor profiling assessments (i.e., matched therapy) in adult pancreatic cancer patie...
What is the current status of trial NCT05914987?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-12-04. Estimated completion is 2033-08-01.
What conditions does trial NCT05914987 study?
This clinical trial studies the following conditions: Pancreatic Neoplasms.
What interventions are being tested in trial NCT05914987?
The interventions under investigation include: Targeted Therapy (OTHER).
Who is sponsoring clinical trial NCT05914987?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05914987 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
RECRUITING
-
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
RECRUITING · Phase 2
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
-
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
-
Pancreatic Cancer Detection Consortium
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.